Skip to main content
The Journal of Pediatrics: X logoLink to The Journal of Pediatrics: X
. 2020 May 12;2:100021. doi: 10.1016/j.ympdx.2020.100021

Factors Associated with Caregiver Sleep Quality Related to Children with Rare Epilepsy Syndromes

Dale C Hesdorffer 1, Barbara L Kroner 2, Jing Shen 1, Kathleen Farrell 3, Steve Roberds 4, Brandy Fureman 3,; Rare Epilepsy Network Steering Committee Steering Committee, on behalf of the
PMCID: PMC10236549  PMID: 37332626

Abstract

Objective

To evaluate the impact of pediatric sleep disturbances and night-time seizure monitoring of children with rare epilepsy syndromes on the sleep quality and mental health of caregivers.

Study design

A cross-sectional study was conducted using caregiver entered data from the Rare Epilepsy Network on pediatric sleep disturbances and Patient Reported Outcomes Measurement Information System measures for caregiver fatigue, sleep disturbance, sleep-related impairment, depression, anxiety, companionship, and cognition. Logistic regression was used to examine associations between risk factors and caregiver sleep quality.

Results

Non-Hispanic white mothers comprised 83% of the 742 respondents in this study. After adjusting for covariates, difficulty falling asleep, excessive daytime sleepiness, frequent night-time awakenings, and very restless sleep in children were associated with fatigue (aOR 95% CI, 1.5-2.2), sleep-related disturbance (aOR 95% CI, 1.7-2.6) and sleep impairment (aOR 95% CI, 1.5-2.4) in caregivers. Caregiver anxiety (aOR 95% CI, 3.6-6.0) and depression (aOR 95% CI, 2.8-6.0) were also highly associated with their fatigue and sleep quality, whereas companionship (aOR 95% CI, 0.3-0.4) and higher caregiver cognition (aOR 95% CI, 0.1-0.2) were protective. In addition, sharing a room or bed or using methods that require listening for seizures were significantly related to sleep disturbance and fatigue in the caregivers.

Conclusions

In rare epilepsies, pediatric sleep disturbances and night-time seizure monitoring are significantly associated with caregiver fatigue and poor sleep quality. In addition to the intense caregiving needs of children with rare epilepsies, fatigue and poor sleep quality in caregivers may contribute to or result from mental health problems.

Keywords: caregiver, pediatric epilepsy, sleep, nocturnal monitoring, SUDEP


See editorial, p 100022

Pediatric epilepsy, a common neurologic disorder,1,2 is associated with substantial burdens on both affected children and their caregivers.3,4 Similar to other childhood chronic illnesses,5,6 altered sleep patterns, such as frequent night-time checking and co-sleeping, have been reported in caregivers of children with epilepsy.7, 8, 9 Individuals with rare epilepsies (eg, Dravet syndrome, Lennox-Gastaut syndrome) may suffer from higher risks for psychiatric disorders,10,11 somatic disorders, and drug-resistant seizures12,13 compared with the general epilepsy population, which may further alter a caregiver's sleep pattern and impair their sleep quality.

Sleep deprivation is among the most common seizure triggers in those with epilepsy. Nocturnal seizures disrupt sleep and increase daytime drowsiness in patients, also increasing the risk of daytime seizures. Nocturnal seizures are a risk factor for sudden unexpected death in epilepsy (SUDEP).

For children aged 0-17 years who live with a rare epilepsy, SUDEP is estimated to account for at least 0.22 deaths per 1000 patient-years,14 which may underestimate the incidence of SUDEP.15,16 Of note, the incidence of SUDEP can be substantially higher in children with rare epilepsies (eg, Dravet syndrome) compared with the general epilepsy population,17,18 possibly owing to refractory seizures and medical complexity. It has been consistently reported that SUDEP occurs much more often at night than in daytime,19 which may be related to the relatively poor supervised environment at night and the severity of nocturnal seizures.20,21 Nocturnal monitoring has been suggested to have a protective effect against SUDEP,22,23 although the data are limited to 1 case control study. In addition to monitoring for nocturnal seizures to record frequency, providing necessary interventions (such as a rescue medication), or comforting the child, caregivers who are aware of SUDEP may be more inclined to monitor their children during sleep, which may in turn impair their own sleep quality.

Nonetheless, compared with extensive investigations on sleep disorders in individuals with epilepsy, caregiver sleep quality is understudied. We therefore conducted this cross-sectional study to examine risk factors for caregiver sleep disturbance, fatigue, and sleep-related impairment, focusing on children with rare epilepsies. Based on current understanding of nocturnal seizure burden, seizure worry, and SUDEP, we hypothesized a priori that caregiver perceived mental burden and strategies of nocturnal monitoring would negatively affect their sleep. In addition, we examined the association between pediatric sleep disturbances and caregiver sleep quality.

Methods

This study used a cross-sectional design in examining survey data from the Rare Epilepsy Network (REN). The REN was initiated by members of the Epilepsy Leadership Council to establish a registry of individuals with rare epilepsy syndromes or rare disorders with a high incidence of epilepsy. After informed consent was obtained, data in the REN were collected from caregivers of affected individuals or from cognitively able affected adults at both baseline and follow-up visits. In this study, we used only the caregiver data from 742 parents and grandparents of affected individuals who were living in the same household. Data included came from the REN survey domains of child and caregiver demographic information, seizure characteristics, child comorbid psychiatric and somatic conditions, and caregiver quality of life at baseline. Outcome variables (caregiver fatigue, sleep disturbance, and sleep impairment) were reported by the 742 eligible caregivers at baseline, which served as the basis of our analysis. This study was approved by the Institutional Review Boards of Columbia University and RTI International.

Patient-Reported Outcomes Measurement Information System

The Patient-Reported Outcomes Measurement Information System (PROMIS)24,25 is a set of self- or proxy-completed measures that evaluates quality of life in adults and children. The REN assessed aspects of the caregiver's quality of life using PROMIS Short Forms v1.0–Anxiety 8a, Depression 8a, Companionship 8a, Fatigue 8a, Sleep Disturbance 8a, and Sleep Related Impairment 8a. Sleep disturbance evaluates the quality of sleep during the night. Sleep impairment evaluates the quality of sleep on daytime functioning. Raw PROMIS scores were converted into T-scores for standardization to the general US population using the PROMIS scoring guidelines. Specifically, PROMIS T-scores were designed with a mean of 50 and a SD of 10. Higher scores represent more of the concept being measured. Clinically actionable thresholds of greater than 60 for PROMIS measures for depression, anxiety, and sleep disturbance have been used by clinical providers.26

We evaluated caregiver sleep quality based on the PROMIS fatigue, sleep disturbance, and sleep-related impairment instruments.27 These instruments have been validated.27,28 The PROMIS sleep disturbance instruments were designed to measure self-reported perceptions of sleep quality, sleep depth, and restoration associated with sleep over the past seven days in adults.29,30 The PROMIS sleep-related impairment instrument was designed to assess self-reported perceptions of alertness and tiredness during usual waking hours, and perceived functional impairment during wakefulness associated with sleep problems or impaired alertness over the past seven days in adults. The PROMIS fatigue instruments assess self-reported perceptions from mild feelings of tiredness to an overwhelming, debilitating sense of exhaustion decreasing one's ability to execute daily activities and normal function.31

Risk Factors

Three clusters of risk factors for caregiver fatigue, sleep disturbance, and sleep-related impairment were examined in this study. The first cluster included pediatric sleep disturbance (symptom or condition related to sleep, difficulty falling asleep, excess daytime sleepiness, frequent night-time awakenings, and very restless sleep), and nocturnal seizure. The second cluster consisted of nocturnal monitoring strategies used by caregivers, including sharing a bed or room with someone, audio monitor use, a seizure alert device use, a seizure response dog use, leaving the door open during sleep, watching or checking the child frequently during the night, and doing nothing to monitor for seizures. The third cluster included caregiver mental and social health conditions, including anxiety, depression, cognition, and companionship (ie, perceived availability of someone with whom to share delightful activities).

Statistical Analyses

Caregiver's characteristics and distributions of risk factors were presented as frequencies (percentages). Binary variables of caregiver's anxiety, depression, cognition, companionship, fatigue, sleep disturbance and sleep-related impairment were created using a cutoff PROMIS T-score of 60 (1 SD above the mean, with T-scores of >60 coded as yes and those ≤60 coded as no). Bivariate and multivariable logistic regressions were used to examine the associations between risk factors and caregiver fatigue, sleep disturbance and sleep-relation impairment. In multivariable logistic regression models, the child's age and caregiver's sex, ethnicity, marital status, educational level, and annual household income were included as covariates. Two-tailed P values of less than .05 were considered statistically significant for all tests. All analyses were performed using SAS 9.4 (SAS Institute, Cary, North Carolina).

Results

Our final analysis included 742 caregivers (median age, 40 years; range, 22-79 years). Thirty-two respondents were excluded because they did not live with the affected person (n = 28) or they were not a parent or grandparent of the affected person (2 spouses, 1 daughter, 1 niece). The majority of caregivers included were mothers (91.0%) and non-Hispanic white (85.3%). In terms of marital status, 85.4% of caregivers were married or had a domestic partner. Of note, more than one-third of caregivers were unemployed. Almost one-fourth of caregivers had an annual household income of less than $50 000, and 36.9% of caregivers had an annual household income of more than $100 000 (Table I).

Table I.

Demographics of 742 caregivers at baseline

Demographic characteristics N (%)
Age, years, median (range) 40 (22-79)
Sex
 Male 60 (8.1)
 Female 682 (91.9)
Race
 American Indian or Alaskan Native 4 (0.5)
 Asian 15 (2.0)
 Black or African American 9 (1.2)
 Native Hawaiian or Pacific Islander 0
 White or Caucasian 675 (91.0)
 Mixed/other 34 (4.6)
 Missing 5 (0.7)
Ethnicity
 Hispanic 61 (8.2)
 Non-Hispanic 677 (91.2)
 Missing 4 (0.5)
Education
 High school/GED or below 55 (7.4)
 Some college 200 (27.0)
 Bachelor's degree 269 (36.3)
 Post graduate school 214 (28.8)
 Missing 4 (0.5)
Marital status
 Single, divorced, separated, widowed 105 (14.2)
 Married, domestic partnership 634 (85.4)
 Missing 3 (0.4)
Household income
 <$50 000 164 (22.1)
 $50 000-$100 000 226 (30.5)
 >$100 000 274 (36.9)
 Missing 78 (10.5)
Employment
 Employed (full or part time) 447 (60.2)
 Unemployed (including retired, disabled) 253 (34.1)
 Paid caregiver 25 (3.4)
 Student/other 15 (2.0)
 Missing 2 (0.3)
Relationship to affected person
 Mother 675 (91.0)
 Father 60 (8.1)
 Grandmother 7 (0.9)

The children with rare epilepsies had a mean age of 8.6 years, with 84 (11.3%) under 2 years of age at the time of enrollment and were diagnosed with more than 30 different epilepsy-related syndromes, disorders, or gene mutations (Table II). The most common syndromes were tuberous sclerosis complex (16.6%), Lennox Gastaut syndrome (13.9%), Dravet syndrome (13.5%), and Aicardi syndrome (8.0%). Seizure burden in the children was significant, with more than 42.4% having more than 100 seizures in the 6 months before enrollment. Tonic-clonic, myoclonic, and tonic were the primary seizure types in 497 (67.0%), and 566 (76.3%) had a rescue medication at home that parents could use to stop or attenuate prolonged seizures (Table II).

Table II.

Demographics and epilepsy characteristics of 742 affected persons at baseline

Child characteristics N (%)
Age, years, median (range) 8.6 (0.3-49.8)
Age group
 0-23 months 84 (11.3)
 2-5 years 182 (24.5)
 6-9 years 142 (19.1)
 10-14 years 152 (20.5)
 ≥15 years 182 (24.5)
Primary epilepsy syndrome
 Aicardi syndrome 59 (8.0)
 CDKL5 mutation 18 (2.4)
 Doose syndrome 42 (5.7)
 Dravet syndrome 100 (13.5)
 Dup15q mutation 36 (4.9)
 Hypothalamic hamartoma 40 (5.4)
 West syndrome 38 (5.1)
 Lennox Gastaut syndrome 103 (13.9)
 Ohtahara syndrome 7 (0.9)
 PCDH19 mutation 26 (3.5)
 Phelan McDermid syndrome 26 (3.5)
 SCN8A 17 (2.3)
 SYNGAP mutation 11 (1.5)
 Tuberous sclerosis complex 123 (16.6)
 Other encephalopathy or genetic mutation 59 (8.0)
 Other rare syndrome/diagnosis 37 (5.0)
Total seizure in previous 6 months
 None 100 (13.5)
 1-5 75 (10.1)
 6-24 80 (10.8)
 25-100 109 (14.7)
 101-200 70 (9.4)
 >200 245 (33.0)
 Missing 63 (8.5)
Current seizure types (not mutually exclusive)
 Tonic-clonic, myoclonic, and/or tonic 497 (67.0)
 Atonic (drop) 264 (35.6)
 Infantile/juvenile spasms 257 (34.6)
 Focal (complex or simple partial) 447 (60.2)
 Gelastic (seizure with laughing or crying) 187 (25.2)
 Missing 126 (17.0)
Rescue medication at home
 Yes 566 (76.3)
 No 154 (20.8)
 Missing 22 (3.0)
Nocturnal seizures
 Always or sometimes 514 (69.3)
 Rarely, never, or don't know 228 (30.7)
Nocturnal seizure monitoring
 Audio monitor (with or without video) 214 (28.8)
 Monitoring device with an alert 93 (12.5)
 Share a bed with someone 121 (16.3)
 Share a room with someone 62 (8.4)
 Door left open 108 (14.6)
 Frequent checks or watching at bedside 19 (2.6)
 Seizure response dog 2 (0.3)
 No monitoring 113 (15.2)
 Missing 10 (1.3)

Angelman (n = 2), congenital bilateral perisylvian syndrome (n = 2), electrical status epilepticus in slow wave sleep (n = 5), Jeavons (n = 3), KCNQ2 (n = 2), Landau Kleffner (n = 4), lissencephaly (n = 1), progressive or other myoclonic epilepsy (n = 4), Rasmussen's encephalopathy (n = 2), Ring 14 (n = 3), Ring 20 (n = 2), SCN2A (n = 3), SLC13A5 (n = 2), Unverricht Lundborg (n = 2).

Risk Factors

It is notable that 69.3% of pediatric patients (n = 514) were affected by nocturnal seizures sometimes or always. Caregivers used a variety of methods to monitor for nocturnal seizures, the most common being using an audio monitor (28.8%), someone sharing a bed with the affected person (16.3%), leaving the door open to listen for seizures (14.6%), and using a monitoring device with an alert (12.5%) (Table II). Among the 84 children under the age of 2 years, the most common monitoring methods were using an audio monitor (32.1%) and sharing a room (22.6%). In addition to nocturnal seizures, there was a high prevalence of reported frequent night-time awakenings (48.8%), difficulties falling asleep (42.7%), and very restless sleep (37.9%) in the affected children (Table III, Table IV, Table V).

Table III.

Logistic regression for risk factors by fatigue T-score

Risk factors Fatigue
T score ≤60, N (%)
Fatigue
T score >60, N (%)
N in logistic model aOR (95% CI) Adjusted P value
Characteristics of child
 Any sleep condition below 221 (55.4) 202 (67.1) 700 2.0 (1.4-2.7) <.001
 Difficulty falling asleep 156 (39.5) 141 (47) 695 1.5 (1.1-2.07) .01
 Excess daytime sleepiness 109 (28) 112 (37.8) 685 1.8 (1.3-2.5) .001
 Frequent night-time awakenings 173 (43.8) 165 (55.2) 694 1.8 (1.3-2.5) <.001
 Very restless sleep 121 (31.1) 138 (47.3) 681 2.2 (1.6-3.1) <.001
 Nocturnal seizures 282 (69.1) 222 (71.6) 718 1.3 (0.9-1.8) .12
Methods for night-time monitoring
 Someone shares a room or bed with the person with epilepsy 91 (22.4) 87 (28.2) 715 1.9 (1.2-3.3) .01
 Audio monitor or seizure alert device or leave door open 231 (56.9) 174 (56.3) 715 1.7 (1.1-2.7) .03
 Watch or check frequently 5 (1.2) 12 (4.2) 715 5.3 (1.8-17.9) .04
 No night-time monitoring 79 (19.5) 35 (11.3) 715 ref
Caregiver PROMIS scores
 Cognition T score >60 146 (35.4) 20 (6.4) 724 0.1 (0.1-0.2) <.001
 Companionship T score >60 133 (32.3) 44 (14.1) 724 0.3 (0.2-0.4) <.001
 Depression T score >60 34 (8.2) 101 (32.5) 724 6.0 (3.9-9.6) <.001
 Anxiety T score >60 75 (18.2) 176 (56.4) 724 6.0 (4.2-8.7) <.001

P values <.05 are in bold.

OR adjusted for caregiver sex, ethnicity, education, marital status, and household income, and child's age. Reference group for all OR includes those without the condition/risk factor except for methods for night-time monitoring.

Table IV.

Logistic regression for risk factors by sleep disturbance T-score

Risk factors Sleep disturbance
T score ≤60, N (%)
Sleep disturbance
T score >60, N (%)
No. in logistic model aOR (95% CI) Adjusted P value
Characteristics of child
 Any sleep condition below 288 (56.4) 137 (70.6) 705 1.9 (1.3-2.8) <.001
 Difficulty falling asleep 199 (39.2) 100 (52.1) 700 1.7 (1.2-2.5) .002
 Excess daytime sleepiness 143 (28.5) 78 (41.5) 689 1.8 (1.3-2.5) .002
 Frequent night-time awakenings 224 (44.1) 116 (60.7) 699 2.0 (1.4-2.9) <.001
 Very restless sleep 157 (31.4) 103 (55.1) 686 2.6 (1.9-3.8) <.001
 Nocturnal seizures 351 (67.1) 156 (77.6) 724 1.7 (1.1-2.5) .009
Methods for night-time monitoring
 Someone shares a room or bed with the person with epilepsy 126 (24.1) 54 (27.1) 721 2.8 (1.5-5.6) .002
 Audio monitor or seizure alert device or leave door open 282 (54.0) 126 (63.3) 3.1 (1.7-5.8) <.001
 Watch or check frequently 13 (2.5) 5 (2.5) 2.7 (0.7-8.7) .1
 No night-time monitoring 101 (19.4) 14 (7.1) ref
Caregiver PROMIS scores
 Cognition T score >60 150 (28.4) 17 (8.4) 730 0.2 (0.1-0.4) <.001
 Companionship T score >60 151 (28.6) 26 (12.9) 730 0.4 (0.2-0.6) <.001
 Depression T score >60 75 (14.2) 60 (29.7) 730 2.8 (1.9-4.2) <.001
 Anxiety T score >60 142 (27.9) 110 (54.5) 730 3.6 (2.5-5.1) <.001

P values <.05 are in bold.

OR adjusted for caregiver gender, ethnicity, education, marital status and household income, and child's age. Reference group for all OR includes those without the condition/risk factor except for methods for night-time monitoring.

Table V.

Logistic regression for risk factors by sleep impairment T-score

Risk factors Sleep impairment
T score ≤60, N (%)
Sleep impairment
T score >60, N (%)
No. in logistic model aOR (95% CI) Adjusted P value
Characteristics of child
 Any sleep condition below 261 (56.9) 164 (66.7) 705 1.7 (1.2-2.4) .003
 Difficulty falling asleep 175 (38.4) 124 (50.8) 700 1.8 (1.3-2.5) <.001
 Excess daytime sleepiness 131 (29.3) 90 (37.2) 689 1.5 (1.1-2.2) .01
 Frequent night-time awakenings 205 (45.1) 136 (55.3) 699 1.6 (1.2-2.3) .004
 Very restless sleep 141 (31.4) 119 (50.2) 686 2.4 (1.7-3.4) <.001
 Nocturnal seizures 324 (68.7) 183 (72.6) 724 1.3 (0.9-1.9) .1
Methods for night-time monitoring
 Someone shares a room or bed with the person with epilepsy 110 (23.5) 70 (27.8) 721 1.5 (0.9-2.6) .1
 Audio monitor or seizure alert device or leave door open 265 (56.5) 143 (56.8) 1.5 (0.9-2.3) .1
 Watch or check frequently 9 (1.9) 9 (3.6) 2.4 (0.9-6.9) .1
 No night-time monitoring 85 (18.1) 30 (11.9) ref
Caregiver PROMIS scores
 Cognition T score >60 154 (32.4) 13 (5.1) 730 0.1 (0.1-0.2) <.001
 Companionship T score >60 144 (30.3) 33 (12.9) 730 0.3 (0.2-0.4) <.001
 Depression T score >60 50 (10.5) 85 (33.5) 730 4.5 (3.0-6.7) <.001
 Anxiety T score >60 108 (22.7) 144 (56.5) 730 4.3 (3.1-6.1) <.001

P values <0.05 are in bold.

OR adjusted for caregiver gender, ethnicity, education, marital status and household income, and child's age. Reference group for all OR includes those without the condition/risk factor except for methods for night-time monitoring.

Caregiver Fatigue, Sleep Disturbance, and Sleep-Related Impairment

Factors of pediatric sleep disturbance, including symptoms or conditions related to sleep, difficulty falling asleep, excess daytime sleepiness, frequent night-time awakenings, and very restless sleep were significantly associated with caregiver fatigue after adjusting for covariates (Table III; aOR 1.5-2.2). There was no association between pediatric nocturnal seizures and caregiver fatigue. Sharing a room or bed or using a listening method was significantly associated with a 1.7- to 1.9-fold odds for increased caregiver fatigue compared with no night-time monitoring. Watching the child sleep or checking on them frequently was significantly associated with an aOR of 5.3 for increased caregiver fatigue compared with no monitoring. Caregiver anxiety and depression were positively associated with caregiver fatigue (aOR, 6.0; P < .001), and caregiver cognition and companionship were inversely associated with caregiver fatigue (aOR, 0.1-0.3; P < .001).

Very restless sleep among the children was significantly associated with a 2.6-fold odds (95% CI, 1.9-3.8) for caregiver sleep disturbance and a 2.4-fold odds (95% CI, 1.7-3.4) for caregiver sleep-related impairment after adjusting for covariates. Frequent night-time awakenings in the child were also significantly associated with caregiver sleep disturbance (aOR, 2.0; 95% CI, 1.4-2.9) and caregiver sleep-related impairment (aOR, 1.6; 95% CI, 1.2-2.3). Pediatric symptoms or conditions related to sleep, difficulty falling asleep, and excess daytime sleepiness were also significantly associated with increased risk for caregiver sleep disturbance (aOR, 1.7-1.9) as well as sleep-related impairment (aOR, 1.5-1.7) (Tables IV and V). The presence of pediatric nocturnal seizures was significantly associated with caregiver sleep disturbance (aOR, 1.7; 95% CI, 1.1-2.5) but not sleep-related impairment (Tables IV and V).

Among the methods for monitoring of nocturnal seizures, sharing a bed or room was significantly associated with a 2.8-fold odds (95% CI, 1.5-5.6) and using a method to listen for seizures (audio monitor, alert device or leaving the door open) was significantly associated with a 3.1-fold odds (95% CI, 1.7-5.8) for caregiver sleep disturbance compared with caregivers who did not monitor for nocturnal seizures. Watching the child sleep or checking on them frequently during the night had no association with sleep disturbance. None of the methods for monitoring of nocturnal seizures were associated with caregiver sleep impairment (Tables IV and V).

Caregiver self-reported anxiety was significantly associated with a 3.6-fold odds (95% CI, 2.5-5.1) and a 4.3-fold odds (95% CI, 3.1-6.1) for caregiver sleep disturbance and sleep-related impairment, respectively (Tables IV and V). Similarly, caregiver depression was significantly associated with a 2.8-fold odds (95% CI, 1.9-4.2) and a 4.5-fold odds (95% CI, 3.0-6.7) for caregiver sleep disturbance and sleep-related impairment, respectively. In contrast, caregiver perceived companionship and higher cognition were inversely associated with caregiver sleep disturbance (aOR, 0.2-0.4; P < .001) and caregiver sleep-related impairment (aOR, 0.1-0.3; P < .001).

Discussion

In this cross-sectional analysis of caregiver entered data in the REN, we identified a number of factors related to caring for children with rare epilepsy syndromes that were significantly associated with caregiver fatigue, sleep disturbance, and sleep-related impairment. These novel findings provide valuable information on health-related impacts of caregiving for children with rare epilepsies, and factors that can be targeted to improve sleep quality in those caregivers.

People with epilepsy who suffer with nocturnal seizures have increased risk for SUDEP compared with those without nocturnal seizures.32,33 Although it has been suggested that nocturnal seizure involved a more severe SUDEP burden,21 another study suggested that an unsupervised environment instead of severity of nocturnal seizure would better explain SUDEP during sleep time.20 Limited by the current understanding of the pathogenesis of SUDEP and the lack of clinical trials studying preventive approaches, there are now guidelines for SUDEP prevention available to caregivers.14 A case control study showed a protective effect of nocturnal supervision against SUDEP in the general epilepsy population22; however, a recent meta-analysis suggested that the proposed preventive effect of nocturnal supervision was of very low-quality evidence.23 Caregivers of children with epilepsy generally fear nocturnal seizures and SUDEP in affected children,34 which may drive them to pursue certain nocturnal monitoring strategies. The pediatric patients in this study had a surprisingly high prevalence of nocturnal seizures (69%), and more than 83% of our caregivers were reported to adopt at least 1 method of nocturnal monitoring.

Our findings showed that pediatric nocturnal seizures were highly associated with caregiver sleep disturbance, but not for caregiver fatigue or sleep-related impairment, suggesting that caregiver's sleep patterns are affected by the unpredictable nature and worry of nocturnal seizures and SUDEP. Larson et al showed that parents of children with epilepsy were much more likely to co-sleep or share a room with pediatric patients than the general population.9 In this study, sharing a bed or room was practiced among a subset of caregivers (25%), which was significantly associated with a detrimental effect on caregiver sleep disturbance and fatigue. Other nocturnal monitoring approaches used by caregivers in this study, including an audio monitor (29%), a seizure alert device (13%), and door open (15%), were also associated with sleep disturbance and fatigue, but not for sleep-related impairment, suggesting that caregivers find ways to compensate during their waking hours for the impact of sleep disturbance and fatigue so that they can carry out daily responsibilities. A pilot study suggested that a seizure detection device may decrease parental fear for nocturnal seizure and co-sleeping arrangements, and improve quality of life in parents of people with epilepsy.35 However, we failed to find a protective effect of the seizure alert device use on caregiver sleep quality and fatigue in this study. To date, seizure alert devices based on various mechanisms have been developed.36, 37, 38, 39, 40 However, the efficacy of seizure alert devices is highly seizure type related,41 and no study yet has compared efficacy and effectiveness among those devices in people with rare epilepsies.42 One study suggested that patients and caregivers were generally interested in seizure detection devices, and the most valued feature of those devices was the ability to detect seizure.43 The relatively low use of seizure detection devices in our caregivers may reflect their low confidence in those devices. Therefore, continuously upgrading seizure alert devices and further studies validating the efficacy and effectiveness of those devices in children with rare epilepsies are warranted.

Accumulated evidence has suggested that children with epilepsy are susceptible to sleep disorders, which may in turn exacerbate seizures.44, 45, 46, 47 Sleep disorders are common in typical children and more commonly reported in children with epilepsy.48,49 In this study, difficulty falling asleep, frequent night-time awakenings, and very restless sleep of affected children were suggested to contribute to both caregiver sleep disturbance and sleep-related impairment. It is reasonable that pediatric sleep disturbance affects caregiver sleep quality, because caregivers usually closely monitor affected children during their sleep, using strategies such as co-sleeping and bed sharing. Therefore, caregivers might continuously check affected children who were having difficulty falling asleep, have frequent night-time awakenings or sleep very restlessly to comfort them or confirm that they are not having nocturnal seizures.

It has been suggested that caregivers of children with epilepsy are more likely to suffer from anxiety and depression.50,51 In the present study, caregiver anxiety and depression were associated with substantial detrimental effects on caregiver sleep quality and fatigue; their perceived companionship and cognition, in contrast, seemed to be strongly protective for sleep quality and fatigue. Therefore, our findings might suggest that caregiver mental well-being could function as a mediator between pediatric epilepsy and caregiver sleep quality and fatigue. Nevertheless, owing to the cross-sectional nature of this study, temporality could not be set between caregiver mental health conditions and their sleep quality or fatigue. In addition, a bidirectional association between caregiver mental health and factors like sleep quality and fatigue could theoretically exist. Therefore, future prospective studies are needed to infer better the causality between perceived mental health burdens and sleep quality and fatigue in caregivers of children with epilepsy.

Several limitations should be noted in this work. First, the cross-sectional study design limits causal inference. Second, our data were not sufficient to allow us to determine whether affected individuals required overnight interventions, such as feeding or medical treatments that would affect sleep in the caregivers. We did not specifically assess the impact of discontinuous timescales of seizure activity (such as seizure clustering) on caregiver reports; some caregivers may have reported perceived impacts during very frequent seizure periods and others may have reported impacts during periods of fewer seizures. All data were entered by caregivers online and have not been validated through medical records. However, the misclassification of both exposure and outcome variables are reasonably considered as nondifferential, which likely drives their associations towards the null. Finally, this study was based on caregivers of children with rare epilepsies, and the respondent population was almost all white, non-Hispanic females who were highly educated and relatively affluent. Therefore, our findings may not be generalizable to the full population of caregivers of people with epilepsy.

Overall our study demonstrates that most caregivers of children with rare epilepsies employ some kind of nocturnal seizure monitoring strategy during children's sleep. When children with rare epilepsies had any of the sleep conditions studied (difficulty falling asleep, excess daytime sleepiness, frequent night-time awakenings, or very restless sleep), caregivers reported significant impact on fatigue, sleep disturbance, and sleep-related impairment. However, nocturnal seizure monitoring approaches may also impose risk on caregiver's levels of fatigue and sleep disturbance. Caregiver perceived mental well-being is strongly associated with their sleep quality. These findings suggest that caring for a person with a rare epilepsy syndrome is associated with significant sleep disruption, fatigue, and sleep impairment in the caregiver. Sleep impairment has repercussions on caregiver mental health, as well as physical health. Sleep deprivation may also influence the daytime interactions with the affected child (eg, a fatigued parent may not be able to engage as fully during play time with the affected child, or to participate as meaningfully with siblings and other family members or to be more effective at work, as compared with a better-rested parent). Our study suggests that mental health problems should be actively evaluated and addressed in caregivers who suffer from fatigue, sleep disturbance and sleep related impairment. In addition, providers should be proactive about probing for sleep conditions in children with rare epilepsy, because treating these issues is likely to benefit both child and caregiver. Future prospective studies are warranted to confirm these findings, infer causality, and generalize these findings to a broader range of caregivers of people with epilepsy.52

Data Statement

Data sharing statement available at www.jpeds.com.

Acknowledgments

We thank all the caregivers who contributed to the Rare Epilepsy Network. We would also like to show our gratitude to the directors of all organizations in the Network for sharing their wisdom with us during the Steering Committee Meetings.

Footnotes

Funded in part by the Patient Centered Outcomes Research Institute (PPRN-1306-04577) and the Epilepsy Foundation. The authors declare no conflicts of interest.

Contributor Information

Brandy Fureman, Email: bfureman@efa.org.

Rare Epilepsy Network Steering Committee Steering Committee:

Brianne McDonald, Lynn Egan, Monika Jones, Monica Weldon, Michael Harris, Kim Rice, Vinez Campbell, Juliann Brandish, Cindy Kercheval, Nichole Villas, Mary Ann Meskis, Vanessa Vogel-Farley, Ilene Miller, Mike Bartenhagen, Heidi Grabenstatter, Karen Utley, Paige Nues, Angela Cherry, Gina Vozenilek, Scotty Sims, Tracy Dixon Salazar, Christina SanInocencio, Stephanie Forman, Nora Wong, Kim Bischoff, Julie Walters, Megan O’Boyle, Geraldine Bliss, Audrey Davidow, Lisa Schoyer, Yssa DeWoody, Kira Wagner, Michael Arcieri, Amber Freed, Kim Nye, Jo Anne Nakagawa, and JayEtta Hecker

Appendix

List of organizations of the Rare Epilepsy Network (Steering Committee Representative)

Aaron's Ohtahara Foundation (Brianne McDonald, Omaha, NE)

Aicardi Syndrome Foundation

Alternating Hemiplegia of Childhood Foundation (Lynn Egan, Southfield, MI)

Brain Recovery Project: Childhood Epilepsy Surgery Foundation (Monika Jones, Los Angeles, CA)

Bridge the Gap SYNGAP (Monica Weldon, Cypress, TX)

Carson Harris Foundation (Michael Harris, Glen Arm, MD)

Chelsea's Hope (Kim Rice, Sacramento, CA)

CSWS Epilepsy & Landau Kleffner Syndrome (ESES) Foundation (Vinez Campbell, Williamsburg, VA)

The Cute Syndrome Foundation (Juliann Brandish, Troy, NY)

Doose Syndrome Epilepsy Alliance (Cindy Kercheval, Colorado Springs, CO)

Dravet Syndrome Foundation (Nichole Villas and Mary Ann Meskis, Cherry Hill, NJ)

Dup15q Alliance (Vanessa Vogel-Farley, Highland Park, IL)

Epilepsy Foundation

Hope for Hypothalamic Hamartoma (Ilene Miller, JD, Waddell, AZ)

Infantile Spasms Community (Mike Bartenhagen)

International Foundation for CDKL5 Research (Heidi Grabenstatter, PhD and Karen Utley, Wadsworth, OH)

International Rett Syndrome Foundation (Paige Nues, Cincinnati OH)

The Jack Pribaz Foundation (Angela Cherry and Gina Vozenilek, Winfield, IL)

KCNQ2 Cure Alliance (Scotty Sims, Denver, CO)

Lennox-Gastaut Syndrome Foundation (Tracy Dixon Salazar, PhD and Christina SanInocencio, MS, Bohemia, NY)

Liv4TheCure (Stephanie Forman, Latham, NY)

The NORSE Institute (Nora Wong, Boston, MA)

The Neurofibromatosis Network (Kim Bischoff, Wheaton, IL)

PCDH19 Alliance (Julie Walters, Novato, CA)

Phelan–McDermid Syndrome Foundation (Megan O'Boyle and Geraldine Bliss, Osprey, FL)

Pitt Hopkins Research Foundation (Audrey Davidow, Winston-Salem, NC)

RASopathies Network (Lisa Schoyer, Altadena, CA)

Ring 14 USA Outreach (Yssa DeWoody, PhD, Midland, TX)

Ring Chromosome 20 Alliance (Kira Wagner and Michael Arcieri, York, PA)

SLC6A1 Connect (Amber Freed, Denver, CO)

TESS foundation (Kim Nye, Menlo Park, CA)

Tuberous Sclerosis Alliance (Jo Anne Nakagawa, Silver Spring, MD)

Wishes for Elliott (JayEtta Hecker, Washington, DC)

Supplementary Data

Data Profile
mmc1.xml (297B, xml)

References

  • 1.Fiest K.M., Sauro K.M., Wiebe S., Patten S.B., Kwon C.S., Dykeman J., et al. Prevalence and incidence of epilepsy: a systematic review and meta-analysis of international studies. Neurology. 2017;88:296–303. doi: 10.1212/WNL.0000000000003509. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Aaberg K.M., Bakken I.J., Lossius M.I., Lund Søraas C., Håberg S.E., Stoltenberg C., et al. Comorbidity and childhood epilepsy: a nationwide registry study. Pediatrics. 2016;138 doi: 10.1542/peds.2016-0921. pii: e20160921. [DOI] [PubMed] [Google Scholar]
  • 3.Chong L., Jamieson N.J., Gill D., Singh-Grewal D., Craig J.C., Ju A., et al. Children's experiences of epilepsy: a systematic review of qualitative studies. Pediatrics. 2016;138 doi: 10.1542/peds.2016-0658. pii: e20160658. [DOI] [PubMed] [Google Scholar]
  • 4.Jensen M.P., Brunklaus A., Dorris L., Zuberi S.M., Knupp K.G., Galer B.S., et al. The humanistic and economic burden of Dravet syndrome on caregivers and families: implications for future research. Epilepsy Behav. 2017;70:104–109. doi: 10.1016/j.yebeh.2017.02.003. [DOI] [PubMed] [Google Scholar]
  • 5.Meltzer L.J., Mindell J.A. Impact of a child's chronic illness on maternal sleep and daytime functioning. Arch Intern Med. 2006;166:1749–1755. doi: 10.1001/archinte.166.16.1749. [DOI] [PubMed] [Google Scholar]
  • 6.Meltzer L.J., Moore M. Sleep disruptions in parents of children and adolescents with chronic illnesses: prevalence, causes, and consequences. J Pediatr Psychol. 2008;33:279–291. doi: 10.1093/jpepsy/jsm118. [DOI] [PubMed] [Google Scholar]
  • 7.Williams J., Lange B., Sharp G., Griebel M., Edgar T., Haley T., et al. Altered sleeping arrangements in pediatric patients with epilepsy. Clin Pediatr. 2000;39:635–642. doi: 10.1177/000992280003901102. [DOI] [PubMed] [Google Scholar]
  • 8.Cottrell L., Khan A. Impact of childhood epilepsy on maternal sleep and socioemotional functioning. Clin Pediatr. 2005;44:613–616. doi: 10.1177/000992280504400709. [DOI] [PubMed] [Google Scholar]
  • 9.Larson A.M., Ryther R.C., Jennesson M., Geffrey A.L., Bruno P.L., Anagnos C.J., et al. Impact of pediatric epilepsy on sleep patterns and behaviors in children and parents. Epilepsia. 2012;53:1162–1169. doi: 10.1111/j.1528-1167.2012.03515.x. [DOI] [PubMed] [Google Scholar]
  • 10.Sillanpaa M., Besag F., Aldenkamp A., Caplan R., Dunn D.W., Gobbi G. Psychiatric and behavioural disorders in children with epilepsy (ILAE task force report): epidemiology of psychiatric/behavioural disorder in children with epilepsy. Epileptic Disord. 2016 doi: 10.1684/epd.2016.0809. in press. [DOI] [PubMed] [Google Scholar]
  • 11.Richards C., Jones C., Groves L., Moss J., Oliver C. Prevalence of autism spectrum disorder phenomenology in genetic disorders: a systematic review and meta-analysis. Lancet Psychiatry. 2015;2:909–916. doi: 10.1016/S2215-0366(15)00376-4. [DOI] [PubMed] [Google Scholar]
  • 12.Chiron C., Dulac O. The pharmacologic treatment of Dravet syndrome. Epilepsia. 2011;52(Suppl 2):72–75. doi: 10.1111/j.1528-1167.2011.03007.x. [DOI] [PubMed] [Google Scholar]
  • 13.Hancock E.C., Cross H.H. Treatment of Lennox-Gastaut syndrome. Cochrane Database Syst Rev. 2009:Cd003277. doi: 10.1002/14651858.CD003277. [DOI] [PubMed] [Google Scholar]
  • 14.Harden C., Tomson T., Gloss D., Buchhalter J., Cross J.H., Donner E., et al. Practice guideline summary: sudden unexpected death in epilepsy incidence rates and risk factors: report of the guideline development, dissemination, and implementation subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology. 2017;88:1674–1680. doi: 10.1212/WNL.0000000000003685. [DOI] [PubMed] [Google Scholar]
  • 15.Devinsky O., Friedman D., Cheng J.Y., Moffatt E., Kim A., Tseng Z.H. Underestimation of sudden deaths among patients with seizures and epilepsy. Neurology. 2017;89:886–892. doi: 10.1212/WNL.0000000000004292. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Sveinsson O., Andersson T., Carlsson S., Tomson T. The incidence of SUDEP: a nationwide population-based cohort study. Neurology. 2017;89:170–177. doi: 10.1212/WNL.0000000000004094. [DOI] [PubMed] [Google Scholar]
  • 17.Cooper M.S., McIntosh A., Crompton D.E., McMahon J.M., Schneider A., Farrell K., et al. Mortality in Dravet syndrome. Epilepsy Res. 2016;128:43–47. doi: 10.1016/j.eplepsyres.2016.10.006. [DOI] [PubMed] [Google Scholar]
  • 18.Kalume F. Sudden unexpected death in Dravet syndrome: respiratory and other physiological dysfunctions. Respir Physiol Neurobiol. 2013;189:324–328. doi: 10.1016/j.resp.2013.06.026. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Devinsky O., Hesdorffer D.C., Thurman D.J., Lhatoo S., Richerson G. Sudden unexpected death in epilepsy: epidemiology, mechanisms, and prevention. Lancet Neurol. 2016;15:1075–1088. doi: 10.1016/S1474-4422(16)30158-2. [DOI] [PubMed] [Google Scholar]
  • 20.Peng W., Danison J.L., Seyal M. Postictal generalized EEG suppression and respiratory dysfunction following generalized tonic-clonic seizures in sleep and wakefulness. Epilepsia. 2017;58:1409–1414. doi: 10.1111/epi.13805. [DOI] [PubMed] [Google Scholar]
  • 21.Latreille V., Abdennadher M., Dworetzky B.A., White D., Katz E., Zarowski M., et al. Nocturnal seizures are associated with more severe hypoxemia and increased risk of postictal generalized EEG suppression. Epilepsia. 2017;58:e127–e131. doi: 10.1111/epi.13841. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Langan Y., Nashef L., Sander J.W. Case-control study of SUDEP. Neurology. 2005;64:1131–1133. doi: 10.1212/01.WNL.0000156352.61328.CB. [DOI] [PubMed] [Google Scholar]
  • 23.Maguire M.J., Jackson C.F., Marson A.G., Nolan S.J. Treatments for the prevention of Sudden Unexpected Death in Epilepsy (SUDEP) Cochrane Database Syst Rev. 2016;7:Cd011792. doi: 10.1002/14651858.CD011792.pub2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Reeve B.B., Hays R.D., Bjorner J.B., Cook K.F., Crane P.K., Teresi J.A., et al. Psychometric evaluation and calibration of health-related quality of life item banks: plans for the Patient-Reported Outcomes Measurement Information System (PROMIS) Med Care. 2007;45:S22–S31. doi: 10.1097/01.mlr.0000250483.85507.04. [DOI] [PubMed] [Google Scholar]
  • 25.Cella D., Yount S., Rothrock N., Gershon R., Cook K., Reeve B., et al. The Patient-Reported Outcomes Measurement Information System (PROMIS): progress of an NIH Roadmap cooperative group during its first two years. Med Care. 2007;45:S3–S11. doi: 10.1097/01.mlr.0000258615.42478.55. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Nagaraja V., Mara C., Khanna P.P., Namas R., Young A., Fox D.A., et al. Establishing clinical severity for PROMIS® measures in adult patients with rheumatic diseases. Qual Life Res. 2018;27:755–764. doi: 10.1007/s11136-017-1709-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Yu L., Buysse D.J., Germain A., Stover A., Dodds N.E., Johnston K.L., et al. Development of short forms from the PROMIS sleep disturbance and sleep-related impairment item banks. Behav Sleep Med. 2011;10:6–24. doi: 10.1080/15402002.2012.636266. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Buysse D.J., Yu L., Moul D.E., Stover A., Dodds N.E., Johnston K.L., et al. Development and validation of patient-reported outcome measures for sleep disturbance and sleep-related impairments. Sleep. 2010;33:781–792. doi: 10.1093/sleep/33.6.781. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.PROMIS sleep-related impairment scoring manual - assessment center. https://www.assessmentcenter.net/documents/PROMIS Sleep-Related Impairment Scoring Manual.pdf
  • 30.PROMIS sleep disturbance scoring manual - assessment center. https://www.assessmentcenter.net/documents/PROMIS Sleep Disturbance Scoring Manual.pdf
  • 31.PROMIS fatigue scoring manual - assessment center. https://www.assessmentcenter.net/documents/PROMIS Fatigue scoring Manual.pdf
  • 32.Lamberts R.J., Thijs R.D., Laffan A., Langan Y., Sander J.W. Sudden unexpected death in epilepsy: people with nocturnal seizures may be at highest risk. Epilepsia. 2012;53:253–257. doi: 10.1111/j.1528-1167.2011.03360.x. [DOI] [PubMed] [Google Scholar]
  • 33.Devinsky O. Sudden, unexpected death in epilepsy. N Engl J Med. 2011;365:1801–1811. doi: 10.1056/NEJMra1010481. [DOI] [PubMed] [Google Scholar]
  • 34.Kroner B.L., Wright C., Friedman D., Macher K., Preiss L., Misajon J., et al. Characteristics of epilepsy patients and caregivers who either have or have not heard of SUDEP. Epilepsia. 2014;55:1486–1494. doi: 10.1111/epi.12799. [DOI] [PubMed] [Google Scholar]
  • 35.Borusiak P., Bast T., Kluger G., Weidenfeld A., Langer T., Jenke A.C.W., et al. A longitudinal, randomized, and prospective study of nocturnal monitoring in children and adolescents with epilepsy: effects on quality of life and sleep. Epilepsy Behav. 2016;61:192–198. doi: 10.1016/j.yebeh.2016.05.035. [DOI] [PubMed] [Google Scholar]
  • 36.Park Y., Luo L., Parhi K.K., Netoff T. Seizure prediction with spectral power of EEG using cost-sensitive support vector machines. Epilepsia. 2011;52:1761–1770. doi: 10.1111/j.1528-1167.2011.03138.x. [DOI] [PubMed] [Google Scholar]
  • 37.Larsen S.N., Conradsen I., Beniczky S., Sorensen H.B. Detection of tonic epileptic seizures based on surface electromyography. Conf Proc IEEE Eng Med Biol Soc. 2014;2014:942–945. doi: 10.1109/EMBC.2014.6943747. [DOI] [PubMed] [Google Scholar]
  • 38.Poh M.Z., Loddenkemper T., Swenson N.C., Goyal S., Madsen J.R., Picard R.W. Continuous monitoring of electrodermal activity during epileptic seizures using a wearable sensor. Conf Proc IEEE Eng Med Biol Soc. 2010;2010:4415–4418. doi: 10.1109/IEMBS.2010.5625988. [DOI] [PubMed] [Google Scholar]
  • 39.van Elmpt W.J., Nijsen T.M., Griep P.A., Arends J.B. A model of heart rate changes to detect seizures in severe epilepsy. Seizure. 2006;15:366–375. doi: 10.1016/j.seizure.2006.03.005. [DOI] [PubMed] [Google Scholar]
  • 40.Beniczky S., Polster T., Kjaer T.W., Hjalgrim H. Detection of generalized tonic-clonic seizures by a wireless wrist accelerometer: a prospective, multicenter study. Epilepsia. 2013;54:e58–e61. doi: 10.1111/epi.12120. [DOI] [PubMed] [Google Scholar]
  • 41.Ulate-Campos A., Coughlin F., Gainza-Lein M., Fernandez I.S., Pearl P.L., Loddenkemper T. Automated seizure detection systems and their effectiveness for each type of seizure. Seizure. 2016;40:88–101. doi: 10.1016/j.seizure.2016.06.008. [DOI] [PubMed] [Google Scholar]
  • 42.Jory C., Shankar R., Coker D., McLean B., Hanna J., Newman C. Safe and sound? A systematic literature review of seizure detection methods for personal use. Seizure. 2016;36:4–15. doi: 10.1016/j.seizure.2016.01.013. [DOI] [PubMed] [Google Scholar]
  • 43.Patel A.D., Moss R., Rust S.W., Patterson J., Strouse R., Gedela S., et al. Patient-centered design criteria for wearable seizure detection devices. Epilepsy Behav. 2016;64:116–121. doi: 10.1016/j.yebeh.2016.09.012. [DOI] [PubMed] [Google Scholar]
  • 44.Eliashiv D., Avidan A.Y. Seizures in sleep: clinical spectrum, diagnostic features, and management. Crit Care Clin. 2015;31:511–531. doi: 10.1016/j.ccc.2015.03.009. [DOI] [PubMed] [Google Scholar]
  • 45.Malow B.A. The interaction between sleep and epilepsy. Epilepsia. 2007;48(Suppl 9):36–38. doi: 10.1111/j.1528-1167.2007.01400.x. [DOI] [PubMed] [Google Scholar]
  • 46.Kothare S.V., Kaleyias J. Sleep and epilepsy in children and adolescents. Sleep Med. 2010;11:674–685. doi: 10.1016/j.sleep.2010.01.012. [DOI] [PubMed] [Google Scholar]
  • 47.Nunes M.L. Sleep and epilepsy in children: clinical aspects and polysomnography. Epilepsy Res. 2010;89:121–125. doi: 10.1016/j.eplepsyres.2009.10.016. [DOI] [PubMed] [Google Scholar]
  • 48.Maski K., Owens J.A. Insomnia, parasomnias, and narcolepsy in children: clinical features, diagnosis, and management. Lancet Neurol. 2016;15:1170–1181. doi: 10.1016/S1474-4422(16)30204-6. [DOI] [PubMed] [Google Scholar]
  • 49.Ekinci O., Isik U., Gunes S., Ekinci N. Understanding sleep problems in children with epilepsy: associations with quality of life, attention-deficit hyperactivity disorder and maternal emotional symptoms. Seizure. 2016;40:108–113. doi: 10.1016/j.seizure.2016.06.011. [DOI] [PubMed] [Google Scholar]
  • 50.Jones C., Reilly C. Parental anxiety in childhood epilepsy: a systematic review. Epilepsia. 2016;57:529–537. doi: 10.1111/epi.13326. [DOI] [PubMed] [Google Scholar]
  • 51.Ferro M.A., Speechley K.N. Depressive symptoms among mothers of children with epilepsy: a review of prevalence, associated factors, and impact on children. Epilepsia. 2009;50:2344–2354. doi: 10.1111/j.1528-1167.2009.02276.x. [DOI] [PubMed] [Google Scholar]
  • 52.Arends J.B., van Dorp J., van Hoek D., Kramer N., van Mierlo P., van der Vorst D., et al. Diagnostic accuracy of audio-based seizure detection in patients with severe epilepsy and an intellectual disability. Epilepsy Behav. 2016;62:180–185. doi: 10.1016/j.yebeh.2016.06.008. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Data Profile
mmc1.xml (297B, xml)

Articles from The Journal of Pediatrics: X are provided here courtesy of Elsevier

RESOURCES